# Research Interest Antiphospholipid in Predicting Embolic Risk During Infective Endocarditis

> **NCT02887079** · — · COMPLETED · sponsor: **Central Hospital, Nancy, France** · enrollment: 186 (actual)

## Conditions studied

- Infective Endocarditis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02887079
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01-01
- **Primary completion:** 2015-12-31
- **Final completion:** 2016-12-31
- **Target enrollment:** 186 (ACTUAL)
- **Last updated:** 2022-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02887079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02887079, "Research Interest Antiphospholipid in Predicting Embolic Risk During Infective Endocarditis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02887079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*